Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses Austria10181776.5Filed on 2002-05-22
Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase Read more about Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase Patent Cooperation TreatyPCT/US2012/044962Filed on 2012-06-29
Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus Read more about Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus Australia2013213749Filed on 2013-08-09
Influenza Hemagglutinin And Neuraminidase Variants Read more about Influenza Hemagglutinin And Neuraminidase Variants Singapore2014010185Filed on 2010-02-03
TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-3 and IL-13 RECEPTOR CHAINS Read more about TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-3 and IL-13 RECEPTOR CHAINS Japan2013-232738Filed on 2000-04-28
Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor Read more about Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor Patent Cooperation TreatyPCT/US2014/043131Filed on 2014-06-19
Vaccination Comprising AMA1 And RON2 Read more about Vaccination Comprising AMA1 And RON2 Patent Cooperation TreatyPCT/US2014/045065Filed on 2014-07-01
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors US Patent 9,403,872Filed on 2014-06-24
Use Of Ixolaris, A Tissue Factor Inhibitor, For Inhibiting Angiogenesis Read more about Use Of Ixolaris, A Tissue Factor Inhibitor, For Inhibiting Angiogenesis US Patent 9,272,023Filed on 2014-05-30
Single-Domain VHH Antiobodies Directed To Norovirus GI.1 And GII.4 And Their Use Read more about Single-Domain VHH Antiobodies Directed To Norovirus GI.1 And GII.4 And Their Use Argentina20140101882Filed on 2014-05-09